Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GlaxoSmithKline PLC Director's Dealing 2015

Jun 9, 2015

5262_dirs_2015-06-09_df10d00c-3c2f-4c9c-97bd-62741de2e2cc.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6255P

GlaxoSmithKline PLC

09 June 2015

GlaxoSmithKline plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities or Connected Persons

In accordance with DTR 3.1.4 R(1)(c) GlaxoSmithKline plc ('GSK') was advised on 9 June 2015 of the following increase in the notional allocation of GSK American Depositary Shares ('ADSs') on 8 June 2015, at a price of $42.24 per ADS, following the revaluation of the cash element of the notional investment held within the GSK 401K plan:

Connected person Number of ADSs
Dr K Slaoui (connected person of Dr M Slaoui) 5

V A Whyte

Company Secretary

9 June 2015

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSKKLBBEQFFBBQ